Table 2.
N (%) | 95% CI | |
---|---|---|
Complete response | 9 (12.7) | 6.8–22.4 |
Partial response | 50 (70.4) | 59.0–79.8 |
Stable disease | 10 (14.1) | 7.8–24.0 |
Progressive disease | 0 (0) | |
Not evaluable | 2 (2.8) | |
Objective response rate | 59 (83.1) | 72.7–90.1 |
N (%) | 95% CI | |
---|---|---|
Complete response | 9 (12.7) | 6.8–22.4 |
Partial response | 50 (70.4) | 59.0–79.8 |
Stable disease | 10 (14.1) | 7.8–24.0 |
Progressive disease | 0 (0) | |
Not evaluable | 2 (2.8) | |
Objective response rate | 59 (83.1) | 72.7–90.1 |